magic. power lunch gets started right now. and let s check where we stand at this hour we re off the highs of the day the dow up 200 points right now, but the session highs were about 100 points above that when we were up more than 300. s&p and nasdaq both up about a percent as well. even though asian markets were down 2% overnight, so a real turnaround for our markets today. and take a look at apple, the stock is jumping after one top analyst says that the tech giant might be tariff proof. we ll explore that a little later this hour, kelly thank you, bill the big news affecting the markets today coming from the g7 meeting in france. it s been changing quickly hourly let s go to eamon javers for the latest yeah, kelly, that s right the president has left the country, air force one was wheels up from biarritz france a short time ago, and that brings to a conclusion the g7 where everybody involved was at pains to strike a message of unity it ended with a fascinating pre
palestinian men. israel is claiming it has taken out a number of hamas leaders. still organized to fire rockets against cities in israel, and we ve seen those barrages pick up again. an investigation into harvard, upenn, m.i.t. after their presidents failed to condemn anti-semitism. a board of advisers calling for a leadership change at upenn. it must be condemned, and condemned unequivocally. good friday morning, i m phil mattingly with poppy harlow in new york. this morning, the 2024 campaign trial is on a collision course with the u.s. justice system. hunter biden now facing nine new federal criminal charges as investigators say he avoided paying $1.4 million in taxes, instead spending that money on things like drugs, escorts, pornography and luxury hotels. hunter biden is not president joe biden and there is no allegation in the 56-page indictment that the president did anything wrong. he s not even mentioned, but that is not stopping house republicans from
. this is nightly business report with tyler mathisen and sue herera. risk assessment. a rare event. the oracle speaks. the big mistake warren buffett said some investors like you may be making. hot topic. ab old drug gets a new price tag to treat a rare and debilitating condition. that and more tonight on nightly business report. welcome. gains were small today. minuscule really. but they were good enough to lift the s&p 500 and nasdaq composite to all-time closing highs. investors seemingly concluded the market had dodged yet another risk. namely, that france might elect a far right opponent of the european union and the euro currency. the french for now voted for a moderate and the status quo. and that was enough to let investors globally focus not on european vote counts, but on the improving health of europe economy and stock market which has been climbing. we begin with two reports. bob pisani takes a look at the markets. but first, michelle caruso-cabrer
show. can t wait for that, but we do begin with new fears about flying. poisoned flight attendants accusing boeing of knowingly endangering airline passengers. cnbc s phil lebeau is in los angeles. give us the story here. reporter: this is the kind of lawsuit that could potentially impact thousands of boeing airplanes being flown around the world. we should point out this is simply allegations at this point. a lawsuit was filed yesterday here in illinois against boeing by four flight attendants. let s set the story up for you involving these flight attendants. they were on a 2013 alaska air flight. four of the flight attendants got sick. three of them passed out. they allege that toxic fumes were fed into the cabin through the air ventilation system. they are blaming the bleed air system which basically brings outside air through the engines, filters it and it s supposed to make it suitable for air to be breathed in the cabin by passengers. the flight attendants say that di
gartman here to explain why one group of stocks are still rallying. but first we start off with the record highs and propelled by biotech up 8% more than double the gains in the health tech sector. that all as president-elect trump is pushing for a quick repeal of obamacare and republicans in the senate and house maneuver to make it a reality. so what is behind this move? is it too late to get in? no, i don t think it is. what is behind the move? what is behind the move is the fact that you haven t heard politicians now effectively talkingabout biotech talk about it the last month. it hasn t been steadfast on everybody s radar screen. so thousand people are lonow pe valuation and maybe the companies are not left to dead. ibb we talk about all the time. look at all through 2016, how many times did to try to get through 250 on the down side? probably four, five, failed to come so each time. now it s above the 280 level that we ve talked about for the last year and a half. and